SEC 13F Intelligence

Managers / Q3 2025 · view latest →

Vazirani Asset Management LLC

CIK 0001716476 · 1540 BROADWAY, SUITE 1600, NEW YORK, NY, 10036 · 646-504-4181

Reported Value
$28M
Q3 2025
Positions
13
Filings on Record
18
2022–present window
Filed
Nov 14, 2025
original filing

Summary

Vazirani Asset Management LLC reported $28M in U.S.-listed holdings across 13 positions for Q3 2025.

The portfolio is heavily concentrated: VRNA alone accounts for 22.9% of reported value.

Compared with Q2 2025, the fund opened 10 new positions and exited 14.

Portfolio Metrics

Turnover
+80.7%
vs prior filed quarter
Top-10 Concentration
+96.8%
share of reported value
Largest Position
+22.9%
Verona Pharma
New / Exited
10 / 14
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’21: $87MQ4 ’21Q1 ’22: $116MQ2 ’22: $77MQ3 ’22: $93MQ3 ’22Q4 ’22: $59MQ1 ’23: $53MQ2 ’23: $59MQ2 ’23Q3 ’23: $65MQ4 ’23: $24MQ1 ’24: $36MQ1 ’24Q2 ’24: $47MQ3 ’24: $56MQ4 ’24: $32MQ4 ’24Q1 ’25: $27MQ2 ’25: $26MQ3 ’25: $28MQ3 ’25Q4 ’25: $16MQ1 ’26: $43Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 75.5%ADR: 22.9%REIT: 1.6%
  • Common Stock · 75.5% · $21M
  • ADR · 22.9% · $6M
  • REIT · 1.6% · $446,600

Quarter-over-Quarter Changes full breakdown →

vs Q2 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
VRNAVERONA PHARMA PLCNEW+60.0K60.0K+$6M$6M
MR COOPER GROUP INCNEW+25.0K25.0K+$5M$5M
NSCNORFOLK SOUTHN CORPNEW+12.5K12.5K+$4M$4M
EAELECTRONIC ARTS INCNEW+10.0K10.0K+$2M$2M
AEBAALLETE INCNEW+27.5K27.5K+$2M$2M
COMPCOMPASS INCNEW+107.7K107.7K+$864,831$864,831
HANESBRANDS INCNEW+125.0K125.0K+$823,750$823,750
PLYMPLYMOUTH INDL REIT INCNEW+20.0K20.0K+$446,600$446,600

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2025

13 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1VRNAVERONA PHARMA PLChistory →SPONSORED ADS22.88%$6M60.0K
2MR COOPER GROUP INCCOM18.83%$5M25.0K
3NSCNORFOLK SOUTHN CORPhistory →COM13.42%$4M12.5K
4FYBRFRONTIER COMMUNICATIONS PAREhistory →COM10.01%$3M75.0K
5EAELECTRONIC ARTS INChistory →COM7.21%$2M10.0K
6SPIRIT AEROSYSTEMS HLDGS INCCOM CL A6.90%$2M50.0K
7AEBAALLETE INChistory →COM NEW6.53%$2M27.5K
8OMCOMNICOM GROUP INChistory →COM5.01%$1M17.2K
9COMPCOMPASS INChistory →CL A3.09%$864,831107.7K
10HANESBRANDS INCCOM2.94%$823,750125.0K
11PLYMPLYMOUTH INDL REIT INChistory →COM1.60%$446,60020.0K
12SURMODICS INCCOM1.07%$298,90010.0K
13XXYCROSS CTRY HEALTHCARE INCCOM0.51%$142,00010.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$43M20May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$16M10Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$28M13Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$26M17Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$27M15May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$32M19Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$56M29Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$47M25Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$36M18May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$24M22Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$65M26Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$59M28Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$53M17May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$59M24Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$93M37Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$77M30Aug 12, 202213F-HRchanges · EDGAR ↗
Q1 2022$116M57May 5, 202213F-HRchanges · EDGAR ↗
Q4 2021$87M51Feb 3, 202213F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.